JP7009685B2 - Chemotherapy support device and chemotherapy support program - Google Patents

Description

The present invention relates to a chemotherapeutic support device and a chemotherapeutic support program that assist a doctor performing cancer treatment using an anticancer agent.

Chemotherapy using an anticancer drug is known for cancer treatment. Drugs, as well as anti-cancer drugs, have a direct effect on the body if the dosage is incorrect. In particular, the dosage is important because anticancer drugs act radically on the body. Techniques for checking such dosages are known (see, for example, Patent Document 1).

In the "drug dose check device and drug dose check method" described in Patent Document 1, when the administration schedule data of the weight of the person who administers the drug is input through the input unit, the control unit administers the drug and the drug. Based on the dose, scheduled dose data, and historical data recalled from the database, it is determined whether the drug dose of the drug to be administered is outside the allowable range of the drug dose recorded in the database. When it is determined that the drug dose is out of the permissible range of the drug dose recorded in the database, the notification unit notifies that the drug dose is "inappropriate".

Japanese Unexamined Patent Publication No. 2016-181134

In the drug dose check device described in Patent Document 1, the dose is checked, but the combined use with other drugs is not considered.
On the other hand, in chemotherapy, the type of drug to be administered to the patient, the standard dose, and the administration schedule are determined by the regimen master. Then, based on this regimen master, the content is changed to suit the patient, and the regimen is ordered for treatment.
However, it is difficult for doctors to grasp the entire contents of the regimen and formulate a dosing schedule for patients.

Therefore, an object of the present invention is to provide a chemotherapeutic support device and a chemotherapeutic support program capable of formulating an administration schedule even if the doctor does not accurately grasp the regimen.

The chemotherapy support device of the present invention is combined with regimen information indicating a regimen including the type of anticancer agent administered to a patient, a standard dose and an administration schedule, and other anticancer agents different from the anticancer agent used in the regimen information. In the storage means in which the regimen master information including duplicate information indicating whether or not the regimen is allowed is stored, and in the period of the administration schedule specified by the regimen information when the regimen order is created based on the regimen information. When a combination with another anticancer agent occurs, it is characterized by comprising an order processing means for determining whether or not duplication is allowed based on the duplication information.

Further, in the chemotherapy support program of the present invention, the computer is different from the regimen information indicating the regimen including the type of anticancer drug administered to the patient, the standard dose and the administration schedule, and the anticancer drug used in the regimemen information. A storage means in which regimen master information including duplicate information indicating whether or not combination with an anticancer drug is permitted is stored, and when a regimen order is created based on the regimemen information, the administration schedule specified by the regimen information. When a combination with another anticancer agent occurs during this period, it is characterized in that it functions as an order processing means for determining whether or not duplication is allowed based on the duplication information.

According to the present invention, when the order processing means creates a regimen order based on the regimen information, when a combination with another anticancer agent occurs during the administration schedule period specified by the regimen information, it is based on the duplicate information. In order to determine whether or not duplication is allowed, when duplication occurs between regimens, it is possible to make an accurate determination without relying on the memory or experience of the doctor.

The duplication information indicates whether or not duplication with all other regimens is permitted, or selectively the duplication with the regimen is permitted, and the duplication possibility information is selectively with the regimen. When indicating that duplication is allowed, it may be provided with duplicate regimen information indicating a regimen in which duplication is allowed.

The duplicate information consists of duplicate possibility information and duplicate regimen information, and indicates whether or not the duplicate possibility information allows duplication with all other regimens, or selectively allows duplication with the regimen. Therefore, the order processing means can determine not only that duplication with other regimens is allowed or not allowed, but also that some regimens are allowed.

According to the present invention, when duplication of regimen occurs, it is possible to make an accurate judgment without relying on the memory and experience of the doctor, so that even if the doctor does not know the regimen accurately, the administration schedule can be determined. It is possible to make a plan.

It is a figure which shows the structure of the chemotherapy support system which concerns on embodiment of this invention. It is a figure for demonstrating the configuration of the processing server which functions as the chemotherapy support apparatus of the chemotherapy support system shown in FIG. It is a figure which shows an example of the regimen list screen. It is a figure which shows an example of the regimen confirmation screen. It is a figure which shows an example of the regimen order screen. It is a figure which shows an example of the warning message screen which is displayed when the upper limit of a dose rate is exceeded. It is a figure which shows an example of the administration schedule screen. It is a figure which shows an example of the order registration confirmation screen. It is a figure which shows an example of the order registration completion screen. It is a figure which shows an example of a course history screen. It is a figure which shows an example of the regimen confirmation screen. It is a figure which shows an example of the regimen reference screen which "Weekly docetaxel" was selected from the regimen list screen shown in FIG. It is a figure which shows an example of the regimen reference screen which "medullary injection" was selected from the regimen list screen shown in FIG. It is a figure which shows an example of the regimen reference screen in which "Rituxan" is selected from the regimen list screen shown in FIG. It is a figure which shows an example of the duplicate information included in the regimen master information stored in the storage means. It is a figure which shows an example of the warning message screen which is displayed when the overlap occurs between the courses which are not allowed to overlap. It is a figure which shows an example of the Day moving screen. It is a figure which shows an example of an order reference screen. It is a figure which shows an example of the confirmation screen at the time of moving a day. It is a figure which shows an example of the Day moving screen. It is a figure which shows an example of an order reference screen.

The chemotherapy support system according to the embodiment of the present invention will be described with reference to the drawings.
In the chemotherapy support system 1 shown in FIG. 1, a processing server 2 functioning as a chemotherapy support device and a plurality of terminal devices 3 operated by each doctor communicate with a LAN which is an example of a telecommunication line in the hospital H. It is connected as possible. An electronic medical record system (not shown) and a terminal device (not shown) operated by a pharmacist at a pharmacy are also connected to this LAN.
The processing server 2, the terminal device 3, the electronic medical record system, and the terminal device operated by the pharmacist may be connected via a WAN. Further, in FIG. 1, a hub, a router, etc., which are relay devices, are not shown.

The processing server 2 is a computer that functions as a chemotherapy support device by operating a chemotherapy program. The processing server 2 transmits screen data to the terminal device 3 by HTTP (Hypertext Transfer Protocol) in response to the operation of the terminal device 3.
The terminal device 3 is, for example, a computer on which a browser that displays screen data transmitted as page data from the processing server 2 operates. Further, the terminal device 3 has a function of operating the input means to transmit the input input data to the processing server 2.

Here, the configuration of the processing server 2 will be described in detail with reference to FIG.
The processing server 2 includes a communication means 21, an order processing means 22, a schedule processing means 23, and a storage means 24.
The communication means 21 has a function of controlling data communication with the LAN.
The order processing means 22 orders the regimen created from the regimen master information stored in the storage means 24 to the terminal device (not shown) operated by the pharmacist at the pharmacy based on the request from the terminal device 3. It has a function.

The schedule processing means 23 has a function of processing the display, change, and the like of the administration schedule.
The storage means 24 stores a chemotherapy program, data used by the chemotherapy program, and the like. Further, the storage means 24 stores regimen information including regimen information including a drug type, drug dose, administration schedule, and the like, and regimen master information including duplicate information described later.

The operation and usage state of the chemotherapy support system according to the embodiment of the present invention configured as described above will be described with reference to the drawings.
The doctor first sets a new order.
The new order can be set from the regimen list screen P1 (see FIG. 3) transmitted to the terminal device 3 by the order processing means 22 of the processing server 2. The regimen list screen P1 is generated based on the regimen master information read by the order processing means 22 from the storage means 24.
The regimen list screen P1 is processed by pressing the new history combined button B11 displayed as "new order / order history" or the list display button B12 displayed as "regimen list" located at the upper left of the screen. It is transmitted from the server 2 to the terminal device 3.

At this time, the patient's physique information (height, weight) read from the electronic medical record system is displayed at the upper part of the regimen list screen P1, and the body surface area and the standard weight based on the physique information are displayed. In this embodiment, as shown in FIG. 3, the height of the patient is set to 91.4 cm for convenience so that the body surface area is 1.000 m ² when calculated by the Du Bois formula.

Further, on the regimen list screen P1, the major classification column R11 is displayed on the left side, and the minor classification column R12 is displayed on the right side. In the major classification column R11, "breast cancer", "stomach cancer", "colon / rectal cancer", and "pancreas / biliary tract cancer", which are major classifications of cancer types, are displayed. When the doctor selects "breast cancer" from this major classification, a list of regimens belonging to the major classification "breast cancer" is displayed in the minor classification column R12. It is assumed that the doctor selects, for example, the regimen name "Weekly docetaxel" from these, highlights it, and then presses the regimen confirmation button B13.

When the press of the regimen confirmation button B13 is transmitted to the processing server 2, the order processing means 22 reads information about the patient from the storage means 24 from the electronic medical record system, and displays the regimen confirmation screen P2 shown in FIG. 4 on the terminal device. Send to 3.

On the regimen confirmation screen P2, the physique information selection field R21 is calculated from the latest patient height, weight and body surface area read from the electronic medical record system, the height, weight and body surface area of the previous course, and the patient's height. The standard weight is displayed. Since the course is the first time (first course) in this order setting, the physique information at the time of the previous course is not displayed.
In addition, on the regimen confirmation screen P2, in the regimen comment display column R22, "Weekly docetaxel" is one course (course) in 28 days, and the weekly medication is continued for 3 weeks (dosing period), and the remaining 1 week is left. It is displayed that the drug is on holiday (drug holiday). Further, on the regimen confirmation screen P2, it is displayed in the recipe display column R23 that the anticancer drug docetaxel intravenous drip infusion will be performed on the first day (Day 1), the eighth day (Day 8), and the 15th day (Day 15). ing.

The doctor operates the input means of the terminal device 3 to select one of the physique information displayed in the physique information selection field R21.
In addition, the doctor designates the number of courses in the course time designation column R24. If it is the first time, the first course, which is the first time, is specified by designating "1" respectively, for example, "this course No." 1 "to" 1 "".
When the selection of the physique information and the designation of the number of courses are completed, the doctor operates the input means of the terminal device 3 and presses the regimen order button B2.

When the press of the regimen order button B2 is transmitted from the terminal device 3 to the processing server 2, the order processing means 22 transmits the regimen order screen P3 shown in FIG. 5 to the terminal device 3.
The regimen order screen P3 is a screen in which detailed information on the patient's test results read from the electronic medical record system is displayed at the upper part, and the dose of the drug can be set.

On the regimen order screen P3, the administration start date setting column R31 for designating the course start date and the recipe display column R32 are displayed as in the regimen confirmation screen P2 (see FIG. 4).
In this recipe display column R32, a dose setting unit S31 reflected in the dose of the drug and a dose setting unit S32 for setting the dose of the drug by the unit "mg" are displayed. Further, on the regimen order screen P3, a regimen master compliance button B31 for setting a dose and a dose based on the regimen master information is displayed.

The doctor sets the dose of the drug in this course as "percent" in the dose setting unit S31, or sets the dose as "mg" in the dose setting unit S32. At this time, the dose of the anticancer drug "docetaxel intravenous drip infusion" was 40 mg at 100%, but the dose was changed to 45 mg.
The dose of 45 mg is about 112.5% (dose rate) with respect to the dose of 40 mg at a dose of 100% on the body surface area of the patient. When the order processing means 22 determines that the upper limit of the dose rate set in the storage means 24, for example, 105%, is exceeded, the warning message screen P31 indicating that the upper limit of the dose rate is exceeded as shown in FIG. 6 is displayed.
In this way, even if an attempt is made to exceed the upper limit of the administration rate, the processing server 2 checks and blocks the setting, so that it is possible to prevent a doctor's setting error.

When the setting on the regimen order screen P3 shown in FIG. 5 is completed, the doctor presses the administration schedule button B32.
When the press of the administration schedule button B32 is transmitted from the terminal device 3 to the processing server 2, the order processing means 22 transmits the administration schedule screen P4 shown in FIG. 7 to the terminal device 3.
On the administration schedule screen P4, in addition to the anticancer drug, a drug administered by infusion (injection) or a drug administered by oral ingestion in the selected regimen corresponds to the administration date in the recipe details column R41. Is displayed. In addition, the administration time is displayed for each administration date.
The doctor confirms the contents of each recipe (RpNo.001 to RpNo.003), and if there is no problem, presses the order registration button B41.

When the pressing of the order registration button B41 is transmitted from the terminal device 3 to the processing server 2, the order processing means 22 displays the order registration confirmation screen P5 (see FIG. 8) for obtaining the final confirmation from the doctor. Send to.
On the order registration confirmation screen P5, an OK button B51 for permitting registration and a cancel button B52 for returning to the original administration schedule screen P4 shown in FIG. 7 are displayed.
Here, when the OK button B51 is pressed, the order processing means 22 stores the contents registered as an order in the storage means 24 as registration regimen information, and displays the order registration completion screen P6 (see FIG. 9). It is transmitted to the terminal device 3. The order registration completion screen P6 indicates that the first course with the regimen name "Weekly Docetaxel" has been ordered.
Further, the order processing means 22 transmits the registered regimemen information in which the first course ordered by the regimemen name “Weekly docetaxel” is ordered to a terminal device (not shown) operated by a pharmacist located in the pharmacy department as a regimemen order. ..

When setting the next course, press the new history combined button B11 located in the upper left and displayed as "new order / order history". By this pressing, the order processing means 22 reads out the course information set in the storage means 24 and transmits the course history screen P7 shown in FIG. 10 to the terminal device 3.

On the course history screen P7, it is displayed that the first course with the regimen name “Weekly Docetaxel” is set from the course period “June 13, 2016” to “July 10, 2016”.
For example, when setting the second course of this regimen, the doctor presses the copy button B71. By this pressing, the order processing means 22 transmits the regimen confirmation screen P8 (see FIG. 11) to the terminal device 3 in the same manner as the regimen confirmation screen P2 shown in FIG.

Since the previous course (first course) is set on the regimen confirmation screen P8, "2" is designated from the beginning in the course time designation column R81.
To register the regimen with the same contents as the first course in the second course, press the regimen order button B8. After that, the first course is continued according to the regimen order screen P3 (see FIG. 5), the administration schedule screen P4 (see FIG. 7), the order registration confirmation screen P5 (see FIG. 8), and the order registration completion screen P6 (see FIG. 9). The second course can also be set.

On the course history screen P7 shown in FIG. 10, when it is desired to order the second course with a new regimen, the new order button B72 is pressed.
When the new order button B72 is pressed, the order processing means 22 can create a new order with a regimen different from that of the first course by transmitting the regimen list screen P1 shown in FIG. 3 to the terminal device 3. can.

Here, the overlap between the courses specified by the regimen information will be described.
The regimen master information stored in the storage means 24 of the processing server 2 includes a setting of whether or not to allow duplication when the regimen courses overlap. This is determined by the combination of anticancer drugs, which are drugs administered to the patient.
The contents of the regimen master information can be referred from the regimen list screen P1 shown in FIG. For example, on the terminal device 3 on which the regimen list screen P1 shown in FIG. 3 is displayed, the regimen reference screen P9 shown in FIG. 12 can be displayed by pressing the regimen reference button B14 after selecting the regimen by operating the input means. It is transmitted from the processing server 2 to the terminal device 3.

The regimen reference screen P9 is a screen when the regimemen name “Weekly docetaxel” is selected, and shows the administration information specified in the regimen master information. Then, when the "regimen duplication" of the duplication setting display unit H91 on the regimen reference screen P9 is referred to, "no duplication" is displayed. Therefore, "Weekly docetaxel" indicates that overlap with any other regimen course (dose period and drug holiday) is not allowed.

For example, on the regimen reference screen P10 shown in FIG. 13, the regimen name “medullary injection” is displayed by the same operation as “Weekly docetaxel”. According to the regimen reference screen P10, the regimen name “medullary injection” is displayed as “duplicate possible” when referring to the “regimen duplication” of the duplicate setting display unit H91.
Therefore, even if the course period of the regimen name "medullary injection" is set so as to overlap with the dosing period or the drug holiday after registering another regimen, the order processing means 22 can be registered.

Further, the regimen reference screen P11 shown in FIG. 14 displays the regimen name “Rituxan” by the same operation as “Weekly docetaxel”. According to the regimen reference screen P11, the regimen name “Rituxan” is displayed as “duplicate possible (limited)” when referring to the “regimen duplication” of the duplicate setting display unit H91.
"Overlapping possible (limited)" indicates that the regimen that overlaps the dosing period and the drug holiday is limited.
For the regimen to which duplication is allowed, the duplication possible regimen display unit H92, which is a list of duplication possible regimemen, is displayed by operating the input means of the terminal device 3 and mouse-overing on the duplication setting display unit H91.
By displaying the duplicateable regimen display unit H92, the doctor can know in advance which regimen is allowed to be duplicated.

This is due to the duplicate information included in the regimen master information stored in the storage means 24. For example, as shown in FIG. 15, in the duplicate information, the overlap possibility information and the duplicate regimen information are associated with the regimen.
The duplication possibility information is information indicating whether or not to allow a combination with another anticancer agent different from the anticancer agent used in the regimen information. The duplication possibility information of the present embodiment is "duplicate possible" that allows duplication with all other regimens, "duplicate not allowed" that does not allow duplication, and duplication is allowed if the regimen is limited. There are three types, "limited".
If the duplication possibility information is "limited", the regimen that allows duplication is stored as the duplication regimen information.

By referring to this duplication information, the order processing means 22 allows duplication possible, non-duplicate, and duplication in the duplication setting display unit H91 and the duplication possible regimen display unit H92, as shown in FIGS. 12 to 14. Regimen can be displayed.

For example, when a period overlapping with another regimen is set in the administration start date setting field R31 of the regimen confirmation screen P3 shown in FIG. 5, the order processing means 22 refers to the duplicate information.
Then, the order processing means 22 is "non-duplicate" or "limited", and the warning message screen to the effect that the periods overlap, provided that the duplicate regimen information does not include the regimen to be duplicated. P12 (see FIG. 16) is transmitted to the terminal device 3.
By doing so, the doctor who operates the terminal device 3 can recognize from the warning message screen P12 that the duplication of the regimens has occurred and that the duplication of the regimens is not allowed, so that the duplication of the regimens occurs. When it occurs, it can be judged accurately without relying on the memory and experience of the doctor. Therefore, it is possible to formulate an administration schedule without knowing the regimen accurately.

In the present embodiment, information for identifying three types of duplication possibility information, whether or not to allow duplication of courses (dose period and drug holiday), or whether to limit the regimen that allows duplication (Fig.). (Refer to 15), six states may be set, such as whether or not the dosing period overlaps, whether or not the drug holiday period overlaps, and whether or not the overlap is allowed.

In other words, there are two types of dosing periods, one is that the dosing period can be overlapped for all regimemens and the other is that the dosing periods cannot be overlapped for all regimemens.
There are two types of drug holidays, one is that the drug holidays can be duplicated for all regimemens and the other is that the drug holidays cannot be duplicated for all regimemens.
Further, when it is limited to the case where duplication is allowed, there are two types of regimens indicating that there is a regimen that allows duplication of medication periods and that there is a regimen that allows duplication of drug holidays.
By using such duplication possibility information, six states can be represented and detailed settings can be made.

Next, the registered regimen can be displayed in a calendar format from the administration schedule screen P4 shown in FIG. 7, and the administration date for administering the drug can be changed.
Press the change button B42 displayed as "Day move" on the administration schedule screen P4. When the change button B42 is pressed, the schedule processing means 23 of the processing server 2 reads the registered registration regimen information from the storage means 24 and displays the course contents in a calendar format on the Day movement screen P13 (see FIG. 17). ) Is transmitted to the terminal device 3.

The Day movement screen P13, which is a calendar screen displayed on the display means on the terminal device 3, is a regimen in which the first course and the second course of "Weekly docetaxel" are registered.
On the Day movement screen P13, an icon C1 imitating a flag indicating the start of the first course and the second course is displayed. A number indicating the course number is displayed on the icon C1 imitating this flag.
Further, on the Day movement screen P13, an icon C2 imitating a drip bag showing drip is displayed on the first day (Day 1), the eighth day (Day 8), and the fifteenth day (Day 15). A number indicating the enforcement date is displayed on the icon C2.
Further, an icon C3 imitating a checkered flag indicating the end of the first course is displayed. In FIG. 17, the icon C3 is not displayed because the end of the second course is August.

With reference to the order reference screen P14 (see FIG. 18) at this time, the patient receives treatment by injection (intravenous drip) from the outpatient department on the 1st, 8th, and 15th days of the administration date of the administration date display column R141. Is displayed.
However, depending on the patient's convenience, it may not be possible to go to the hospital on the day of treatment. For example, when the patient cannot go to the hospital on the 8th day but can go to the hospital on the 9th day, the doctor drags the icon C2 displayed on the 8th day of the Day moving screen P13 shown in FIG. Drop on the 9th day (Day 9).

By this operation by the doctor, the enforcement date is requested to be moved from the terminal device 3 to the processing server 2. In the processing server 2, the schedule processing means 23 transmits the confirmation screen P15 shown in FIG. 19 to the terminal device 3.
On the confirmation screen P15, the buttons B151 and B152 (radio buttons) for selecting whether to move only the injection (drip) or both the injection and the prescription (oral medication) as the date movement, and the schedule after the movement target date. Buttons B153 and B154 (radio buttons) for selecting whether or not to shift are displayed.
Since "Weekly docetaxel" is only an intravenous drip, the doctor specifies the movement of only the injection (drip) by pressing the button B151. In addition, since the doctor does not shift the schedule after the movement target date, the doctor presses the button B154 to specify. Then, the move button B155 displayed as "move" is pressed.

When the press of the move button B155 is notified from the terminal device 3 to the processing server 2, the schedule processing means 23 changes the enforcement date (8th day (Day 8)) before the movement to the enforcement date (9th day (9th day)) after the movement. The storage means 24 stores the movement to the Day 9), and the schedule processing means 23 moves the icon C2 indicating the drip on the 8th day (Day 8) to the 9th day (Day 9), and the icon C2 and the drip. The shape indicating the above and the numerical value indicating the enforcement date are the same, but the icon C4 having a different color is used as the Day moving screen P16 (see FIG. 20) displaying the 8th day (Day 8).
At this time, referring to the order reference screen P17 shown in FIG. 21, "Day 8 (9th day)" is displayed in the enforcement date display column R171, and the injection (intravenous drip) scheduled to be administered on Day 8 is displayed on the 9th day. You can recognize that it has changed.

In this way, on the Day movement screens P13 and P16, when it is desired to move the administration date of the medication to the administration date of the destination, it can be easily moved by drag and drop. In addition, since the icon indicating that the enforcement date has been moved remains as a history on the enforcement date before the move, both the enforcement date before the move and the enforcement date after the move can be confirmed.
Also, on the order reference screens P14 and P17, the enforcement date after the move is displayed in the column of the enforcement date before the move, and the enforcement date before the move is also recorded as a history. You can see both the day and the day.

Therefore, the doctor can determine at a glance when the enforcement date has been moved after the movement.

In the confirmation screen P15 shown in FIG. 19, it is decided not to shift the schedule after the movement target date, but the schedule after the movement target date may be shifted according to the patient's condition.
In this case, on the confirmation screen P15 shown in FIG. 19, the doctor selects the button B153 displayed as "Yes" for "subsequent Day movement", and presses the movement button B155 displayed as "Move". do.
Then, the schedule processing means 23 shifts not only the dosing period of the course including the enforcement date of the movement target but also the drug holiday after the dosing period to the rear, so that the next course is also sequentially shifted. ..
In this way, when the enforcement date of the moving target is moved, the course including the enforcement date of the moving target is shifted, and the next course is also sequentially shifted, so that the enforcement date of the moving target is changed. The administration schedule can be easily changed without the doctor having to rely on manual calculations such as the start date of the next course and the end date of the course.

At this time, depending on the setting, the dosing period may be shifted, but the drug holiday may not be shifted. By doing so, the next course can be carried out on schedule.
However, if the regimen requires a prescribed drug holiday, the dosing period will shift, but if the drug holiday is not shifted, the course that includes the effective date of the transfer target and the next It will overlap with the course.
In this case, the order processing means 22 may determine the overlap between the courses.

The present invention is suitable for a medical institution to which a doctor who performs cancer treatment using an anticancer agent belongs.

1 Chemotherapy support system 2 Processing server 21 Communication means 22 Order processing means 23 Schedule processing means 24 Storage means 3 Terminal device H Hospital P1 Regimen list screen R11 Major classification column R12 Minor classification column B11 New history combined button B12 List display button B13 Regimen Confirmation button B14 Regimen reference button P2 Regimen confirmation screen R21 Regimen information selection column R22 Regimen comment display column R23 Regimen display column R24 Course time designation column B2 Regimen order button P3 Regimen order screen R31 Administration start date setting column R32 Regimen display column S31 Dosage setting Part S32 Dosage setting part B31 Regimen master compliance button B32 Dosing schedule button P31 Warning message screen P4 Dosing schedule screen R41 Recipe details column B41 Order registration button B42 Change button P5 Order registration confirmation screen B51 OK button B52 Cancel button P6 Order registration completed Screen P7 Course history screen B71 Copy button B72 New order button P8 Regimen confirmation screen R81 Course time specification field B8 Regimen order button P9, P10, P11 Regimen reference screen H91 Duplicate setting display H92 Duplicate possible regimen display P12 Warning message screen P13 Day Move screen C1 to C3 icon P14 Order reference screen R141 Enforcement date display column P15 Confirmation screen B151 to B154 button B155 Move button P16 Day move screen P17 Order reference screen R171 Enforcement date display column

Claims (3)

Regimen information indicating the regimen including the type of anticancer drug administered to the patient, standard dose and administration schedule, and duplication indicating whether to allow a combination with another anticancer drug different from the anticancer drug used in the regimen information. A storage means in which regimen master information including information is stored, and
When a regimen order is created based on the regimen information, if a combination with another anticancer drug occurs during the period of the administration schedule specified by the regimen information, whether or not duplication is allowed based on the duplication information. Order processing means to determine
It is equipped with a schedule processing means for displaying and processing changes in the administration schedule .
The schedule processing means has a button for selecting whether to move only the injection or both the injection and the internal medicine when the movement on the enforcement date is requested, and selects whether to shift the schedule after the movement target date. When the button to move is displayed on the display means and the movement is instructed, the administration date of the medication is moved to the destination administration date based on the selected button, and when the scheduled shift is instructed, after the movement target date. Chemotherapy support device that shifts the schedule of . The duplication information indicates whether or not duplication with all other regimens is permitted, or selectively the duplication with the regimen is permitted, and the duplication possibility information is selectively with the regimen. The chemotherapy support device according to claim 1, further comprising duplicate regimen information indicating a regimen in which duplication is allowed, when indicating that duplication is allowed. Computer,
Regimen information indicating the regimen including the type of anticancer drug administered to the patient, standard dose and administration schedule, and duplication indicating whether to allow a combination with another anticancer drug different from the anticancer drug used in the regimen information. A storage means in which regimen master information including information is stored,
When a regimen order is created based on the regimen information, if a combination with another anticancer drug occurs during the period of the administration schedule specified by the regimen information, whether or not duplication is allowed based on the duplication information. Order processing means to determine
It functions as a schedule processing means to process the display and change of the administration schedule .
The schedule processing means has a button for selecting whether to move only the injection or both the injection and the internal medicine when the movement on the enforcement date is requested, and selects whether to shift the schedule after the movement target date. When the button to move is displayed on the display means and the movement is instructed, the administration date of the medication is moved to the destination administration date based on the selected button, and when the scheduled shift is instructed, the movement target date or later is performed. Chemotherapy support program to shift appointments .

Images